Plasma microbiome in COVID-19 subjects: an indicator of gut barrier defects and dysbiosis

The gut is a well-established route of infection and target for viral damage by SARS-CoV-2. This is supported by the clinical observation that about half of COVID-19 patients exhibit gastrointestinal ( GI ) symptoms. We asked whether the analysis of plasma could provide insight into gut barrier dysf...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:bioRxiv
Autors principals: Prasad, Ram, Patton, Michael John, Floyd, Jason L, Vieira, Cristiano Pedrozo, Fortmann, Seth, DuPont, Mariana, Harbour, Angie, Jeremy, Chen See, Wright, Justin, Lamendella, Regina, Stevens, Bruce R., Grant, Maria B.
Format: Artigo
Idioma:Inglês
Publicat: Cold Spring Harbor Laboratory 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8043449/
https://ncbi.nlm.nih.gov/pubmed/33851159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.04.06.438634
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars